Macrophage inflammatory protein 1-alpha (MIP-1alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells


  • S. Lentzsch
  • M. Gries
  • M. Janz
  • R. Bargou
  • B. Doerken
  • M.Y. Mapara


  • Blood


  • Blood 101 (9): 3568-3573


  • Recently, it has been demonstrated that macrophage inflammatory protein 1- alpha (MIP-1{alpha}) is crucially involved in the development of osteolytic bone lesions in multiple myeloma (MM). The current study was designed to determine the direct effects of MIP-1{alpha} on MM cells. Thus, we were able to demonstrate that MIP-1{alpha} acts as a potent growth, survival, and chemotactic factor in MM cells. MIP-1{alpha}–induced signaling involved activation of the AKT/protein kinase B (PKB) and the mitogen-activated protein kinase (MAPK) pathway. In addition, inhibition of AKT activation by phosphatidylinositol 3- kinase (PI3-K) inhibitors did not influence MAPK activation, suggesting that there is no cross talk between MIP-1{alpha}–dependent activation of the PI3-K/AKT and extracellular-regulated kinase (ERK) pathway. Our data suggest that besides its role in development of osteolytic bone destruction, MIP-1{alpha} also directly affects cell signaling pathways mediating growth, survival, and migration in MM cells and provide evidence that MIP-1{alpha} might play a pivotal role in the pathogenesis of MM.